Article
Residual Convolutional Neural Network for the Determination of IDH Status in Low- and High-Grade Gliomas from MR Imaging.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Mar 2018
Chang Ken, Bai Harrison X, Zhou Hao, Su Chang, Bi Wenya Linda, Agbodza Ena, Kavouridis Vasileios K, Senders Joeky T, Boaro Alessandro, Beers Andrew, Zhang Biqi, Capellini Alexandra, Liao Weihua, Shen Qin, Li Xuejun, Xiao Bo, Cryan Jane, Ramkissoon Shakti, Ramkissoon Lori, Ligon Keith, Wen Patrick Y, Bindra Ranjit S, Woo John, Arnaout Omar, Gerstner Elizabeth R, Zhang Paul J, Rosen Bruce R, Yang Li, Huang Raymond Y, Kalpathy-Cramer Jayashree
Abstract excerpt
Purpose: Isocitrate dehydrogenase (IDH) mutations in glioma patients confer longer survival and may guide treatment decision making. We aimed to predict the IDH status of gliomas from MR imaging by applying a residual convolutional neural network to preoperative radiographic data.Experimental Design: Preoperative imaging was acquired for 201 patients from the Hospital of University of Pennsylvania (HUP), 157...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
